Fortis Healthcare Secures Fortis Trademark Ownership For ₹200 Crore

Fortis Healthcare Limited has officially acquired ownership of the ‘Fortis’ trademark following a long-standing legal dispute. This acquisition was confirmed by the Delhi High Court on 25 March 2025 after a public auction process. The case, originally linked to an arbitration award in favour of Daiichi Sankyo Company Limited, resulted in the sale of the Fortis Marks to Fortis Healthcare for ₹200 crores.

Legal Background and Auction Process

The legal conflict began with an arbitral award issued in April 2016 by a Singapore tribunal, which ruled in favour of Daiichi Sankyo against multiple respondents, including RHC Holding Private Limited. As part of the decree enforcement, the Supreme Court of India ordered in September 2022 that assets linked to the erstwhile promoters, Malvinder and Shivinder Mohan Singh, be made available for auction under the Delhi High Court’s supervision.

On October 29, 2024, the Delhi High Court directed a public auction for the Fortis Marks to settle the decree against Daiichi Sankyo. The auction took place on December 21, 2024, where Fortis Healthcare emerged as the highest bidder with a ₹200 crore offer. Despite objections raised by RHC Healthcare regarding valuation and auction procedures, the Delhi High Court upheld the sale in its final judgment on March 25, 2025.

Confirmation of Ownership and Future Implications

With the court’s confirmation, Fortis Healthcare now holds complete ownership of the Fortis Marks, along with all associated rights and liabilities. The company is free to register the trademark under its name in official records. The next step in the legal proceedings includes finalising the sale deed, scheduled for April 16, 2025.

Financially, the acquisition carries no additional penalties or compensatory obligations for Fortis Healthcare. The judgment secures the brand’s intellectual property, ensuring its exclusive use by the company.

Fortis Healthcare Share Performance 

As of April 03, 2025, at 9:30 AM, Fortis Healthcare share price was trading at ₹669.50, reflecting a surge of 1.04% from its previous closing price. Over the past month, it has surged by 6.42%.

Conclusion

The Delhi High Court’s ruling marks the end of a prolonged legal battle, granting Fortis Healthcare undisputed ownership of its trademark. This resolution reinforces the company’s brand identity and stability while concluding a significant chapter in its corporate history.

Disclaimer: This blog has been written exclusively for educational purposes. The securities mentioned are only examples and not recommendations. This does not constitute a personal recommendation/investment advice. It does not aim to influence any individual or entity to make investment decisions. Recipients should conduct their own research and assessments to form an independent opinion about investment decisions.

Investments in the securities market are subject to market risks, read all the related documents carefully before investing.